How Eczema Is Diagnosed: Why There Is Still No Single Blood Test
Evidence summary for education only; not individualized medical advice.
Diagnosis starts with the pattern
Atopic dermatitis is diagnosed from history and examination: itch, chronic or relapsing course, age-related distribution, barrier dryness and associated atopy. Common frameworks include Hanifin-Rajka, UK Working Party and American Academy of Dermatology criteria.
No confirmatory laboratory marker
A 2026 evaluation-and-work-up review found no consensus objective biomarker that confirms eczema or fully measures severity. Total IgE can be normal in genuine eczema or elevated for unrelated reasons. Eosinophils and allergen tests do not replace examination.
Validated measures answer different questions
EASI and investigator global assessments describe clinician-observed signs. POEM captures patient-reported symptoms. RECAP and ADCT address longer-term control. A person can have modest visible disease at an appointment but severe itch or sleep loss, so combining perspectives is useful.
When additional testing is reasonable
Patch testing may be appropriate when contact allergy is suspected. Targeted food-allergy evaluation follows a convincing immediate-reaction history or specific clinical purpose. Biopsy or other laboratory work may be needed when the course is atypical, adult-onset, treatment-resistant or suggests another disease.
Babies and children
Rashes in infancy include seborrheic dermatitis, contact irritation, infection and genetic disorders. Do not diagnose from an online image alone. Fever, poor feeding, widespread blisters or painful skin needs urgent pediatric evaluation.
Bottom line
Eczema diagnosis is clinical and multidimensional. Tests should resolve a defined uncertainty rather than substitute for history and examination.
Related Dr. Arsy research
- Choosing an eczema moisturizer
- Eczema infection warning signs
- Eczema and sleep
- Eczema across skin tones
- Comparing eczema treatments
- Pediatric eczema education
References
- Evaluation and work-up of atopic dermatitis
- Food allergy testing guideline comparison
- Patch testing in atopic dermatitis consensus
- Infectious complications of atopic dermatitis
- Vaccination during biologic therapy review
- AAAAI/ACAAI GRADE guideline
- 2026 pediatric guideline
- AAD topical therapy guideline
- AAD systemic therapy guideline
- Food allergy and atopic dermatitis review
- Elimination diets systematic review
- Early allergenic-food introduction meta-analysis
- LEAP peanut trial
- Eczema herpeticum review
- Systemic antibiotic use in eczema review
- Topical antimicrobials Cochrane review
- S aureus and eczema review
- Atopic dermatitis microbiome review
- Contact dermatitis clinical review
- Atopic dermatitis clinical review
- HOME core outcome set
- POEM validation
- RECAP control instrument
- Pediatric biologic systematic review
Cited researchers and organizations do not endorse #003.